Advanced Cell Technology Inc. (OTCBB: ACTC) shares subsided 0.9% Thursday to 16.45 cents, on volume of 1.73 million shares.

A news release put out by The Bedford Report on August 24 noted that more North American stem cell research firms have found success forming International partnerships to help boost funding.

According to Bernard Siegel, director of the non-profit Genetics Policy Institute, U.S. stem cell firms are looking to Asia more for partnerships. Siegel is quoted in the Bedford Report as citing two reasons, one having to do with the attractiveness of Asian countries as markets for stem cell treatments, the other with Asia’s lower regulatory hurdles when compared to the U.S.

Based in Santa Monica, Calif., Advanced Cell Technology focuses on the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine.